Core One Labs (FRA:LD6) Cash-to-Debt : 0.62 (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Core One Labs Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Core One Labs's cash to debt ratio for the quarter that ended in Dec. 2023 was 0.62.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Core One Labs couldn't pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Core One Labs's Cash-to-Debt or its related term are showing as below:

FRA:LD6' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.09 Med: 4.32 Max: No Debt
Current: 0.62

During the past 11 years, Core One Labs's highest Cash to Debt Ratio was No Debt. The lowest was 0.09. And the median was 4.32.

FRA:LD6's Cash-to-Debt is ranked worse than
82.79% of 1540 companies
in the Biotechnology industry
Industry Median: 6.485 vs FRA:LD6: 0.62

Core One Labs Cash-to-Debt Historical Data

The historical data trend for Core One Labs's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Core One Labs Cash-to-Debt Chart

Core One Labs Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Cash-to-Debt

Get a 7-Day Free Trial

4.21

1.38

0.09

4.43

28.76

Core One Labs Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Sep23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial															0.85	0.92	N/A	0.90	0.62

Competitive Comparison of Core One Labs's Cash-to-Debt

For the Biotechnology subindustry, Core One Labs's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Core One Labs's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Core One Labs's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Core One Labs's Cash-to-Debt falls into.

Core One Labs Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Core One Labs's Cash to Debt Ratio for the fiscal year that ended in Dec. 2021 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0.604	/	(0.021	+	0)
	=	28.76

Core One Labs's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0.106	/	(0.171	+	0)
	=	0.62

Core One Labs (FRA:LD6) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Core One Labs Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Core One Labs's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Core One Labs (FRA:LD6) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Core One Labs Inc (FRA:LD6) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

CLABF:USA COOL:Canada

Address

1199 West Hastings Street, Suite 800, Vancouver, BC, CAN, V6E 3T5

Website

https://www.core1labs.com

Core One Labs Inc is a psychedelic research and development life sciences enterprise focused on bringing psychedelic medicines to market through novel delivery systems and psychedelic assisted psychotherapy. The company intends to further develop and apply the technology to psychedelic compounds, such as psilocybin. The Company operates a virtual clinic that assesses patients for the appropriateness of treatment plans for the use of medical cannabis to treat their symptoms. The Company partners with physicians and Health Canada's licensed producers for the provision of treatments, fulfillment of prescriptions, and sale of related products.

Core One Labs (FRA:LD6) Headlines

No Headlines